Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Food & Drug Administration (FDA) has approved of intranasal esketamine *blog link* for treatment-resistant depression, which lends support to the safety & efficacy of long-term ketamine for maintenance of symptoms beyond the initial series of infusions
Dosing protocols for disc herniations are extrapolated from studies on other tissues and from clinical experience
The multifaceted role of extracellular vesicles in prostate cancer-a review
Some people feel pain when opening jars, turning doorknobs or doing other everyday activities
Tools like Virtual Examiner and Virtual AuthTech help organizations identify bundling conflicts, missing documentation elements, and high-risk adjudication issues before the claim is submitted
US$ 28.20
US$ 29.56
US$ 25.95
US$ 24.22
US$ 24.17
US$ 21.71
